Emmrich F, Rieber P, Kurrle R, Eichmann K
Max-Planck-Society, Research Unit for Rheumatology/Immunology, Erlangen, FRG.
Eur J Immunol. 1988 Apr;18(4):645-8. doi: 10.1002/eji.1830180425.
Ligand binding under conditions that generate microaggregates of the T cell receptor complex (Ti/CD3) with the membrane molecules CD4 or CD8 can induce activation of small resting T lymphocytes. We demonstrate this by using soluble dimeric heteroconjugates consisting of monoclonal antibodies to CD4/CD8 and of a novel anti-CD3 monoclonal antibody (BMA030) which even in aggregated form is not stimulatory on its own under limiting conditions in the absence of accessory cells. Using combinations of BMA030 with either anti-CD4 or anti-CD8, the corresponding T cell subpopulation could be selectively expanded in vitro. Selective expansion of T cell subpopulations in vitro or in vivo might be helpful for certain therapeutical manipulations. In addition, this finding may contribute to a better understanding of major histocompatibility complex-restricted T cell activation.
在能使T细胞受体复合物(Ti/CD3)与膜分子CD4或CD8形成微聚集体的条件下,配体结合可诱导静止的小T淋巴细胞活化。我们通过使用可溶性二聚体异源缀合物来证明这一点,该异源缀合物由抗CD4/CD8单克隆抗体和一种新型抗CD3单克隆抗体(BMA030)组成,即使在聚集形式下,在没有辅助细胞的有限条件下,其自身也不具有刺激性。将BMA030与抗CD4或抗CD8组合使用,相应的T细胞亚群可在体外选择性扩增。在体外或体内选择性扩增T细胞亚群可能有助于某些治疗操作。此外,这一发现可能有助于更好地理解主要组织相容性复合体限制的T细胞活化。